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Brigitte SchlegelbergerLore Zech (Figure 1) was in a certain way the mother of
modern cytogenetics. Without her major contribution,
i.e. the development of the first chromosome banding
technique to differentiate human chromosomes, modern
cytogenetics would not have become the important tool
for clinical and tumor cytogenetics it is today. During
the 1960s, Lore Zech worked with Torbjörn Caspersson
(15.10.1910-07.12.1997) in the Institute of Cell Research
and Genetics located at the famous “Karolinska Institutet”
in Stockholm, related to Alfred Nobel and his Nobel Prize.
Using DNA-binding fluorescence dyes like quinacrine
mustard, chromosome banding of plant chromosomes had
already been developed there. However, Lore Zech was the
one who was convinced that human chromosomes also
have different bands, an idea that was not supported by the
department head at that time. Working in secret in a small
chamber, she developed the so-called Q-banding technique.
With her special humor she used to tell that the break-
through came when she was able to study “valuable male
blood”, where she recognized a bright chromosome band,
the heterochromatic region of the Y-chromosome [1,2].
In 1971, during the IVth International Congress of Hu-
man Genetics in Paris, she was invited to present her find-
ings, and from there on chromosome bands were widely
accepted and an international nomenclature established.
During the next decades Lore Zech used the Q-banding
technique to identify numerous recurrent chromosome
aberrations in human leukemias and lymphomas.Correspondence: Schlegelberger.Brigitte@MH-Hannover.de
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reproduction in any medium, provided the orThe most important example is the Burkitt translocation
t(8;14)(q24;q32), still the diagnostic hallmark of Burkitt
lymphoma and B-acute lymphoblastic leukemia. She had
received tissue of Burkitt lymphomas, which her esteemed
collaborator Georg Klein (born 28.07.1925) had obtained
from Africa. The description of the Burkitt translocation
was the basis to understand that oncogenes are activated
by juxtaposition with regulatory sequences, i.e. by translo-
cating the C-MYC oncogene into the immunoglobulin
heavy chain locus [3,4]. Likewise, the identification of
small deletions like the deletion of band 13q14 in
B-chronic lymphocytic leukemia (B-CLL) was later
recognized to harbor an important tumor suppressor gene
[5]. Thus, identification of tumor-specific chromosome aber-
rations paved the way for the molecular characterization of
leukemias and lymphomas and finally for development of
targeted therapy [6-15].
Born in Gütersloh, Germany, in 1923, Lore Zech lost both
parents at the age of 4 years. She grew up with her grand-
mother in a rural area, the Sauerland, and began to study
Human Medicine in 1944 in Marburg (Germany). After the
Second World War, it turned out to be impossible to con-
tinue her medical studies and therefore she chose biology,
chemistry and physics as her topics in Bonn (Germany). For
her doctoral thesis, she went to the Max Planck Institute in
Tübingen. In 1953 she followed her husband to Sweden and
worked in the Institute of Cell Research and Genetics in
Stockholm, until 1989. After her “retirement” she joined
the Department of Medical Genetics at the University
Hospital of Uppsala, where she spent every day in-
volved in chromosome and FISH analyses as well as
discussions with many young colleagues.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 Dr. Lore Zech as we knew her.
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http://www.molecularcytogenetics.org/content/6/1/20Last year, she was extremely proud that a PhD student
had dedicated his work to her stating she was his major
inspiration. This characterizes her as empathetic and
widely interested and someone who stimulated the re-
search of numerous colleagues. When she visited confer-
ences, she was always surrounded by scientists and
students, who sought her advice and her company.
One story documents her as a scientist: Lore Zech
had detected, but not published, that the Philadelphia
chromosome (Ph) was due to the translocation t(9;22)(q34;
q11) - she already found that the Ph was a derivative of
chromosome 22 [15] - when her American colleague Janet
Rowley (born 05.04.1925) visited her and wanted to discuss
this finding. She instructed her young colleague how to get
better pictures and let her publish this significant finding
[16]. Everybody knew that Prof. Dr. Lore Zech was always
fair and supportive.
As mentioned above, after her “retirement”, Lore Zech
continued to work in and drive every day to the Institute
of Medical Genetics, University Hospital of Uppsala,
Sweden in her own car. One day, close to her 90th birth-
day, she was stopped in a traffic control and had a hard
time to convince the police officer she was telling the
truth when she replied to his question where she was
going by: ‘I am going to the institute to work there’.
Lore Zech was loved by her colleagues and, with her
wide range of interests she stimulated discussions on
many scientific topics. Particularly for students and younginvestigators, she served as a mentor inspiring and
supporting them by sharing her vast skills and knowledge.
Lore Zech died on 13.3.2013 from the progression of
chronic lymphocytic leukemia, a disease she had investi-
gated for decades.
Lore Zech is deeply missed by all who had the privil-
ege to meet her.
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